SCHEMBL8286347

SCHEMBL8286347

Cc1cc(N2CCc3ccccc3C2)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.54
GRIN2D O15399 12/20 0.43
GRIN3B O60391 12/20 0.43
GRIN1 Q05586 12/20 0.43
GRIN2A Q12879 12/20 0.43
GRIN2B Q13224 12/20 0.43
GRIN2C Q14957 12/20 0.43
GRIN3A Q8TCU5 12/20 0.43
CHRM1 P11229 6/20 0.43
ADRA1D P25100 6/20 0.43
ADRA1A P35348 6/20 0.43
ADRA1B P35368 6/20 0.43
HRH4 Q9H3N8 1/20 0.41
NUDT1 P36639 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
SCN9A Q15858 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285166 0.87 PDE11A (0.60) PDE11AALDH1A1
SCHEMBL8287889 0.86 PDE11A (0.73) PDE11AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8286344 0.86 PDE11A (0.64) PDE11AALDH1A1
SCHEMBL8286346 0.86 PDE11A (0.61) PDE11AALDH1A1
SCHEMBL8286342 0.85 PDE11A (0.60) PDE11AALDH1A1
SCHEMBL5872109 0.83 PDE11A (0.75) PDE11AALDH1A1
SCHEMBL5871598 0.83 PDE11A (0.58) PDE11AALDH1A1
SCHEMBL5871831 0.82 PDE11A (0.57) PDE11AALDH1A1
SCHEMBL8287870 0.81 PDE11A (0.56) PDE11AALDH1A1
SCHEMBL8285164 0.80 PDE11A (0.55) PDE11AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed